Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways

Authors:

Abstract
No abstract available
Funding Information
  • Taipei Medical University Shuang Ho Hospital Ministry of Health and Welfare

This publication has 36 references indexed in Scilit: